[1]
M. S. Montgomery, “Generics And Biosimilars: Mapping The Biosimilars Regulatory Approval Pathway Against The Hatch-Waxman Act And Projecting Futures Effects On The Biologics Market And Patent Protection”, U. Pitt. L. Rev., vol. 75, no. 3, May 2015.